Annual report
8938.TEDINET S100R9UF
Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 143
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥2.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥3.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥89m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥340m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥268m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥346m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥46m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥390m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥347m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥348m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥208m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥255m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥2.2bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥350m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥220m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥8.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥8.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥11.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥22.4bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥426m | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.0bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥945m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.3bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥755m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥196m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥769m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥172m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥695m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥788m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥364m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥276m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥38.47 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.09 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-38.82 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-400.62 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.46 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥23.08 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥867.29 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥835.41 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥811.66 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥669.37 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,083.43 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 93.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.5% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.4% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.9% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.5% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 61 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 62 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 48 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 59 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 59 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥150m | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥222m | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥149m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥422m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥419m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥357m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥380m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.5bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥404m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥307m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥214m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥192m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥125m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥2.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.6bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥7.4bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥7.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥7.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥256m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥536m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥7.2bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.3bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.4bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥2.5bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.0bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-21.23 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.85 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.86 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-432.87 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥286.65 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥172.74 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥773.9 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥801.13 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥814.98 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥456.78 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥894.65 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 94.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.9% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 22.9% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 38.0% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 9,051,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,051,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,051,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,560,400 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,560,400 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 16 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 15 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 10 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 19 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 4 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥452m |
| Company Widereportable segment | employees | at 2023-03-31 | 16 pure |
| Hospital Businessreportable segment | employees | at 2023-03-31 | 45 pure |
| Hospital Related Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥5m |
| Hospital Related Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Hospital Related Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Hospital Related Businessreportable segment | segment assets | at 2023-03-31 | ¥7.0bn |
| Hospital Related Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥416m |
| Real Estate Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥76m |
| Real Estate Businessreportable segment | employees | at 2023-03-31 | 0 pure |
| Real Estate Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥712m |
| Real Estate Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥712m |
| Real Estate Businessreportable segment | segment assets | at 2023-03-31 | ¥1.5bn |
| Real Estate Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥124m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥81m |
| —segment total | employees | at 2023-03-31 | 61 pure |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| —segment total | segment assets | at 2023-03-31 | ¥8.4bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥541m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥81m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥541m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥465m |
| Hospital Related Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥5m |
| Hospital Related Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| Hospital Related Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| Hospital Related Businessreportable segment | segment assets | at 2022-03-31 | ¥6.7bn |
| Hospital Related Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥680m |
| Real Estate Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥110m |
| Real Estate Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥391m |
| Real Estate Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥391m |
| Real Estate Businessreportable segment | segment assets | at 2022-03-31 | ¥2.2bn |
| Real Estate Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥125m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥115m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥2.5bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥2.5bn |
| —segment total | segment assets | at 2022-03-31 | ¥8.9bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥806m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥115m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥8.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥806m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,443
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 2470000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 2470000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E04034-000HospitalRelatedBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E04034-000RealEstateBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E04034-000HospitalRelatedBusinessReportableSegmentsMember | 2079000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E04034-000RealEstateBusinessReportableSegmentsMember | 391000000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 2470000000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 2470000000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YearDuration | 2470000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E04034-000HospitalRelatedBusinessReportableSegmentsMember | 680000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E04034-000RealEstateBusinessReportableSegmentsMember | 125000000 | JPY |
| Operating income | Prior1YearDuration_ReportableSegmentsMember | 806000000 | JPY |
| Operating income | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 806000000 | JPY |
| Operating income | Prior1YearDuration_ReconcilingItemsMember | -465000000 | JPY |
| Operating income | Prior1YearDuration | 340000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E04034-000HospitalRelatedBusinessReportableSegmentsMember | 6694000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E04034-000RealEstateBusinessReportableSegmentsMember | 2205000000 | JPY |
| Assets | Prior1YearInstant_ReportableSegmentsMember | 8900000000 | JPY |
| Assets | Prior1YearInstant_TotalOfReportableSegmentsAndOthersMember | 8900000000 | JPY |
| Assets | Prior1YearInstant_ReconcilingItemsMember | － | JPY |
| Assets | Prior1YearInstant | 8900000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E04034-000HospitalRelatedBusinessReportableSegmentsMember | 5000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E04034-000RealEstateBusinessReportableSegmentsMember | 110000000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReportableSegmentsMember | 115000000 | JPY |
| Depreciation segment information | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 115000000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Depreciation segment information | Prior1YearDuration | 115000000 | JPY |
| Impairment losses segment information | Prior1YearDuration_jpcrp030000-asr_E04034-000HospitalRelatedBusinessReportableSegmentsMember | 3000000 | JPY |
| Impairment losses segment information | Prior1YearDuration_jpcrp030000-asr_E04034-000RealEstateBusinessReportableSegmentsMember | － | JPY |
| Impairment losses segment information | Prior1YearDuration_ReportableSegmentsMember | 3000000 | JPY |
| Impairment losses segment information | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 3000000 | JPY |
| Impairment losses segment information | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Impairment losses segment information | Prior1YearDuration | 3000000 | JPY |
| Investments in entities accounted for using equity method segment information | Prior1YearDuration_jpcrp030000-asr_E04034-000HospitalRelatedBusinessReportableSegmentsMember | 703000000 | JPY |
| Investments in entities accounted for using equity method segment information | Prior1YearDuration_jpcrp030000-asr_E04034-000RealEstateBusinessReportableSegmentsMember | － | JPY |
| Investments in entities accounted for using equity method segment information | Prior1YearDuration_ReportableSegmentsMember | 703000000 | JPY |
| Investments in entities accounted for using equity method segment information | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 703000000 | JPY |
| Investments in entities accounted for using equity method segment information | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Investments in entities accounted for using equity method segment information | Prior1YearDuration | 703000000 | JPY |
| Increase in property plant and equipment equality intangible assets segment information | Prior1YearDuration_jpcrp030000-asr_E04034-000HospitalRelatedBusinessReportableSegmentsMember | 9000000 | JPY |
| Increase in property plant and equipment equality intangible assets segment information | Prior1YearDuration_jpcrp030000-asr_E04034-000RealEstateBusinessReportableSegmentsMember | － | JPY |
| Increase in property plant and equipment equality intangible assets segment information | Prior1YearDuration_ReportableSegmentsMember | 9000000 | JPY |
| Increase in property plant and equipment equality intangible assets segment information | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 9000000 | JPY |
| Increase in property plant and equipment equality intangible assets segment information | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |